Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease

Journal of Virology

Volumn 73, Issue 3, 1999, Pages 1795-1801

  Lawrence, Diane M P ^a   Vaughn, Melinda M ^a   Belman, Alec R ^a   Cole, Joan S ^a   Rall, Glenn F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MEMBRANE COFACTOR PROTEIN; VIRUS RECEPTOR;

ADOLESCENT; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MEASLES VIRUS; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS INFECTION;

EID: 0032978961     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.3.1795-1801.1999     Document Type: Article

References (48)

1. Adkins, B., A. Ghanei, and K. Hamilton. 1993. Developmental regulation of IL-4, IL-2 and IFN-gamma production by murine peripheral T lymphocytes. J. Immunol. 151:6617-6626.
2. Albrecht, P., and H. P. Schumacher. 1971. Neurotropic properties of measles virus in hamsters and mice. J. Infect. Dis. 124:86-93.
3. Alt, F. W., G. Rathbun, E. Oltz, G. Taccioli, and Y. Shinkai. 1992. Function and control of recombination-activating gene activity. Ann. N. Y. Acad. Sci. 651:277-294.
4. Anlar, B. 1997. Subacute sclerosing panencephalitis: diagnosis and drug treatment options. CNS Drugs 7:111-120.
5. Arvin, A. M. 1997. Viral infections of the fetus and neonate, p. 801-814. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, Philadelphia, Pa.
6. Baczko, K., U. G. Liebert, M. Billeter, R. Cattaneo, H. Budka, and V. ter Meulen. 1986. Expression of defective measles virus genes in brain tissues of patients with SSPE. J. Virol. 59:472-478.
7. Bartlett, P. F., R. S. C. Kerr, and K. A. Bailey. 1989. Expression of major histocompatibility antigens in the central nervous system. Transplant. Proc. 21:3163-3165.
8. Billeter, M. A., R. Cattaneo, P. Spielhofer, K. Kaelin, M. Huber, A. Schmid, K. Baczko, and V. ter Meulen. 1994. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann. N. Y. Acad. Sci. 724:367-377.
9. Brosnan, C. F., and C. S. Raine. 1996. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:243-257.
10. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
11. Dhib-Jalbut, S., and K. P. Johnson. 1994. Measles virus diseases, p. 539-554. In R. R. McKendall and W. G. Stroop (ed.), Handbook of neurovirology. Marcel Dekker, New York, N.Y.
12. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305.
13. Finke, D., U. G. Brinckmann, V. ter Meulen, and U. G. Liebert. 1995. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469-5474.
14. Geiger, K. D., T. C. Nash, S. Sawyer, T. Krahl, G. Patstone, J. C. Reed, S. Krajewski, D. Dalton, M. J. Buchmeier, and N. Sarvetnick. 1997. Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. Virology 238:189-197.
15. Gogate, N., P. Swoveland, T. Yamabe, L. Verma, J. Woyciechowska, E. Tarnowska-Dziduszko, J. Dymecki, and S. Dhib-Jalbut. 1986. MHC class I expression on neurons in SSPE and experimental subacute measles encephalitis. J. Neuropathol. Exp. Neurol. 55:435-443.
16. Gopas, J., D. Itzhaky, Y. Segev, S. Salzberg, B. Trink, N. Isakov, and B. Rager-Zisman. 1992. Persistent measles virus infection enhances class I MHC expression and immunogenicity of murine neuroblastoma cells. Cancer Immunol. Immunother. 34:313-320.
17. Griffin, D. E., and W. J. Bellini. 1996. Measles virus, p. 1267-1312. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
18. Griffin, D. E., J. L. Hess, and T. R. Moench. 1987. Immune responses in the central nervous system. Toxicol. Pathol. 15:294-302.
19. Griffin, D. E., J. Mullinix, O. Narayan, and R. T. Johnson. 1974. Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice. Infect. Immun. 9:690-695.
20. Hallensleben, W., M. Schwemmle, J. Hausmann, L. Stitz, B. Volk, A. Pagenstecher, and P. Staeheli. 1998. Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology. J. Virol. 72:4379-4386.
21. Herndon, R. M., and L. J. Rubinstein. 1967. Light and electron microscopy observations in the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis). Neurology 18:8-20.
22. Ikegami, H., M. Takeda, and K. Doi. 1997. An age-related change in susceptibility of rat brain to encephalomyocarditis virus infection. Int. J. Exp. Pathol. 78:101-107.
23. Joly, E., L. Mucke, and M. B. A. Oldstone. 1991. Viral persistence in neurons explained by a lack of MHC class I expression. Science 253:1283-1285.
24. Katayama, Y., H. Hotta, A. Nishimura, Y. Tatsuno, and M. Homma. 1995. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J. Gen. Virol. 76:3201-3204.
25. Katz, M. 1995. Clinical spectrum of measles. Curr. Top. Microbiol. Immunol. 191:1-12.
26. Koprowski, H., and B. Dietzschold. 1998. Rabies: lessons from the past and a glimpse into the future. Curr. Top. Microbiol. Iinmunol. 232:239-257.
27. Kovarik, J., and C.-A. Siegrist. 1998. Immunity in early life. Immunol. Today 19:150-152.
28. Liebert, U. G., and D. Finke. 1995. Measles virus infections in rodents. Curr. Top. Microbiol. Immunol. 191:149-160.
29. Liebert, U. G., S. K. Flanagan, S. Loffler, K. Baczko, V. ter Meulen, and B. K. Rima. 1994. Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J. Virol. 68:1486-1493.
30. Lipkin, W. I., K. L. Tyler, and B. H. Waksman. 1988. Viruses, the immune system and central nervous system diseases. Trends Neurosci. 11:43-45.
31. McGeer, P. L., and E. G. McGeer. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:195-218.
32. Mosier, D. E., and P. L. Cohen. 1975. Ontogeny of mouse T-lymphocyte function. Fed. Proc. 34:137-140.
33. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
34. + T cell subsets in the control of an acute herpes simplex virus infection in skin and nervous system. J. Gen. Virol. 68:825-833.
35. Niewiesk, S., U. Brinckmann, B. Bankamp, S. Sirak, U. G. Liebert, and V. ter Meulen. 1993. Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J. Virol. 67:75-81.
36. Pachner, A. R. 1996. The immune response to infectious diseases of the central nervous system: a tenuous balance. Springer Semin. Immunopathol. 18:25-34.
37. Rall, G. F. 1998. CNS neurons: the basis and benefits of low class I major histocompatibility complex expression. Curr. Top. Microbiol. Immunol. 232: 115-134.
38. Rall, G. F., M. Manchester, L. R. Daniels, E. M. Callahan, A. R. Belman, and M. B. A. Oldstone. 1997. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA 94:4659-4663.
39. Rall, G. F., and M. B. A. Oldstone. 1995. Virus-neuron-cytotoxic T lymphocyte interactions. Curr. Top. Microbiol. Immunol. 202:261-273.
40. Rima, B. K., J. A. P. Earle, K. Baczko, P. A. Rota, and W. J. Bellini. 1995. Measles virus strain variations. Curr. Top. Microbiol. Immunol. 191:65-83.
41. Roos, R. P., D. E. Griffin, and R. T. Johnson. 1978. Determinants of measles virus (hamster neurotropic strain) replication in mouse brain. J. Infect. Dis. 137:722-727.
42. Sidhu, M. S., J. Crowley, A. Lowenthal, D. Karcher, J. Menonna, S. Cook, S. Udem, and P. Dowling. 1994. Defective measles virus in human subacute sclerosing panencephalitis brain. Virology 202:631-641.
43. Streilein, J. W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428-432.
44. Tardieu, M., M. L. Powers, and H. L. Weiner. 1983. Age-dependent susceptibility to reovirus type 3 encephalitis: role of viral and host factors. Ann. Neurol. 13:602-607.
45. Tellez-Nagel, I., and D. H. Harter. 1966. Subacute sclerosing leukoencephalitis: ultrastructure of intranuclear and intracytoplasmic inclusions. Science 154:899-901.
46. Weiner, L. P., and J. O. Fleming. 1984. Viral infections of the nervous system. J. Neurosurg. 61:207-224.
47. Wekerle, H., C. Linington, H. Lassman, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trends Neurosci. 9:271-277.
48. Whitley, R. J., and A. Arvin. 1998. Herpes simplex infections of the central nervous system. Curr. Top. Microbiol. Immunol. 232:258-272.